Biomerica appoints former Meridian CEO Jack Kenny to Board of Directors

BIOMERICA INC

Appointment effective August 25, 2023; Board expanded to add independent director.
Kenny will chair Nominating and Corporate Governance Committee and serve on Audit Committee.
Annual cash fee of $52,500 (paid quarterly); equity compensation to be determined later.
Kenny previously led Meridian Bioscience as CEO, overseeing its $1.53B all-cash sale.
Kenny to support launch of inFoods IBS test, which targets 40M+ U.S. IBS patients.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jack Kenny

Independent Director

BMRA · BIOMERICA INC

Effective: 2023-08-25
Filed: August 28, 2023, 7:59 PM ET

Effective August 25, 2023, the board of directors (the “Board”) of Biomerica, Inc. (the “Company”) expanded the size of the Board by one member and elected and appointed Mr. Jack Kenny to serve as an independent member of the Board effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jack Kenny was appointed as Independent Director at BIOMERICA INC.

Action: appointed
Role: Independent Director

Exact text from the filing

Effective August 25, 2023, the board of directors (the “Board”) of Biomerica, Inc. (the “Company”) expanded the size of the Board by one member and elected and appointed Mr. Jack Kenny to serve as an independent member of the Board effective immediately.

View on SEC.gov

BIOMERICA INC filing history →

Source: SEC EDGAR

accession 0001493152-23-030303

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.